SoftMining

Our Science

Drug and materials discovery pipelines

In addition to working with other companies, SoftMining has achieved important results in many areas. As you can see, we are active in the development of antibiotics, anticancer drugs, and biomaterials.

Early discovery

Discovery

Preclinical

Phase I

Phase II 

Phase III

 

 

Laminar Pharma
Glioblastome
BRC
Breast cancer
SJT-SM
NASH*
SM
Bacteria 1*
SM
Bacteria 2*
SM
ADAR*

* Patent pending

Early discovery

Proof of concept

Patent

Prototype

Market Ready

 

 

SM
Biodegradable controlled materials
SM
Chemical synthesis on metal support
SM-Tecnocap
Biodegradable non toxic PVC replacement
SM
Electrochemical treatment of bacteriousys

APP's pipeline

This represents a side effect of SoftMining research. It all started with the Covid emergency. SoftMining proposed and built (in team with other startups) the first European contact tracing app SM-Covid-19. We were present on Google and Apple stores since April 2020 thanks to the support of Regione Campania (Italy). We filed two patents related to Bluetooth technologies and developed, in record time, multiplatform solutions to support communities in containing the virus. These assets can be sourced or licensed to other companies.

This represents a side effect of SoftMining research. It all started with the Covid emergency. SoftMining proposed and built (in team with other startups) the first European contact tracing app SM-Covid-19. We were present on Google and Apple stores since April 2020 thanks to the support of Regione Campania (Italy). We filed two patents related to Bluetooth technologies and developed, in record time, multiplatform solutions to support communities in containing the virus. These assets can be sourced or licensed to other companies.

BLE Contact tracing
SM-Covid-19
Risk assessment
Convivio*
Social Platform
WIT+*
ECG analysis
EKG*
Semantic analysis
SySA
Tourism assistant
WIT

* Patent pending